U.S. Biosimilars Market report provides detailed information regarding various insights of the industry. Some of them are growth drivers, hindrances, competitive landscape, regional analysis, and challenges.
The “U.S. Biosimilars Market 2020” will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by Fortune Business Insights, titled, “Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026,” The U.S. Biosimilars Market is projected to reach US$ 17,696.0 Mn by 2026. The report provides valuable insights into the drivers influencing growth of the market. As per the report, The U.S. Biosimilars Market is anticipated to report an impressive CAGR of 54.7% during the forecast period. The report also states that the U.S. market was valued at US$ 436.1 Mn in 2018.
Leading Players operating in the U.S. Biosimilars Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
Get Sample PDF Brochure:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-biosimilars-market-100990
Autoimmune Diseases Segment Projected to Dominate the Market in the U.S.
The U.S. biosimilars market is classified into three segments, namely, by distribution channel, by disease indication, and by drug class. By distribution channel, the market is grouped into online pharmacy, hospital pharmacy, and retail pharmacy. In terms of disease indication, the market is divided into cancer and autoimmune diseases such as arthritis, neutropenia, psoriasis, and others. In 2018, the autoimmune diseases held a market share of 92.0%. The segment is anticipated to remain in the leading position the U.S. biosimilars market during the forecast period. Factors like increasing adoption of biosimilars, rise in the prevalence of autoimmune diseases, and availability of limited drugs are likely to boost the segment. The Centers of Disease Control and Prevention declared that approximately 26% adults are estimated to have arthritis by 2040.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market Please visit:https://www.fortunebusinessinsights.com/industry-reports/u-s-biosimilars-market-100990
Market Segmentation:
By Drug Class
By Disease Indication
By Distribution Channel
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-biosimilars-market-100990
Detailed Table of Content:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.1 Prevalence of Key Disease Associated with the Scope – U.S., 2018
4.2 New Product Launch
4.3 Pipeline Analysis
4.4 Regulatory Scenario
4.5. Reimbursement Scenario
4.6. Patent Snapshot of Biologics
4.6 Key Industry Developments – Partnerships, Mergers and Acquisitions
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast By Drug Class
5.2.1 Filgrastim and Pegfilgrastim
5.2.2 Monoclonal Antibodies
5.2.2 Others
5.3. Market Analysis, Insights and Forecast By Disease Indication
5.3.1 Cancer
5.3.2 Autoimmune Diseases
5.3.2.1 Arthritis
5.3.2.2 Psoriasis
5.3.2.3 Neutropenia
5.3.2.4 Others
5.3.3 Others
5.4. Market Analysis, Insights and Forecast By Distribution Channel
5.4.1 Hospital Pharmacy
5.4.2 Retail Pharmacy
5.4.3 Online Pharmacy
6.1. Key Industry Developments
6.2. U.S. Market Share Analysis (2018)
6.3. Competition Dashboard
6.4. Comparative Analysis Major Players
6.5. Company Profiles (Overview, Products and services, SWOT analysis, Recent developments, strategies, financials (based on availability))
6.5.1 Novartis AG
6.5.2 Pfizer Inc.
6.5.3 Coherus BioSciences, Inc.
6.5.4 Teva Pharmaceutical Industries Ltd.
6.5.5 Merck and Co., Inc.
6.5.6 AbbVie Inc.
6.5.7 F. Hoffmann-La Roche Ltd.
6.5.8 Eli Lilly and Company
6.5.9 Celltrion Inc.
6.5.10 Amgen Inc.
6.5.11 Other Prominent Players
Continued…
Reasons to Purchase this Report:
KEY QUESTIONS ANSWERED:
More Trending Topics From Fortune Business Insights@
Assisted Reproductive Technology (ART) Market
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit U.S. Biosimilars Market: Global Size, Share, Emerging Trends, Demand, Revenue and Forecasts Research to 2026